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Abstract
Autosomal recessive cutis laxa type 3A is caused by mutations in ALDH18A1, a
gene encoding the mitochondrial enzyme Δ1-pyrroline-5-carboxylate synthase
(P5CS). It is a rare disorder with only six pathogenic mutations and 10 affected
individuals from five families previously described in the literature. Here we
report the identification of novel compound heterozygous missense mutations
in two affected siblings from a Lebanese family by whole-exome sequencing.
The mutations alter a conserved C-terminal domain of the encoded protein
and reduce protein stability as determined through Western blot analysis of
patient fibroblasts. Patient fibroblasts exhibit a lipid droplet phenotype similar
to that recently reported in Warburg Micro syndrome, a disorder with similar
features but hitherto unrelated cellular etiology.
Syndromic cutis laxa (CL) comprises a group of distinct
but clinically overlapping disorders within which inelastic
wrinkled and redundant skin is a common feature
(Mohamed et al. 2011). It is genetically heterogeneous
and can be categorized according to autosomal dominant,
recessive, or X-linked modes of inheritance. Within the
category of autosomal recessive CL, Type I (ARCL1, MIM
219100, 614437, 613177) is associated with pulmonary
emphysema and poor prognosis. It is caused by mutations
in ELN (MIM 130160), FBLN5 (MIM 604580), EFEMP2
(MIM 604633), or LTBP4 (MIM 604710) which encode
secreted proteins that interact with the extracellular
matrix (ECM)(Elahi et al. 2006; Hucthagowder et al.
2006; Megarbane et al. 2009; Urban et al. 2009). Type II
(ARCL2, MIM 219200, 612940) is associated with
developmental delay, skeletal abnormalities and character-
istic facies. ARCL2 can be caused by mutations in
ATP6V0A2 (MIM 611716) which encodes a component
of a Golgi-localized H+-ATPase (Kornak et al. 2008). A
related disorder, geroderma osteodysplasticum (GO, MIM
231070) is caused by mutations in GORAB (MIM
607983), which encodes a RAB6-interacting Golgin (Hen-
nies et al. 2008). Type III ARCL, also known as De Barsy
syndrome, is associated with cognitive impairment and
motor deficits in addition to developmental delay and
abnormal facies. ARCL3A (MIM 219150) is caused by
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mutations in ALDH18A1 (MIM 138250) and ARCL3B
(MIM 614438) is caused by mutations in PYCR1 (MIM
179035). These genes encode mitochondrial enzymes
involved in proline synthesis, Δ1-pyrroline-5-carboxylate
synthase (P5CS) and pyrroline-5-carboxylate reductase 1,
respectively (Baumgartner et al. 2000; Reversade et al.
2009). Mutations in PYCR1 are a more frequently
reported cause of ARCL3 than mutations in ALDH18A1.
Additionally, reflecting clinical overlap between condi-
tions and possibly also a variable clinical presentation,
PYCR1 mutations have been described as causing
ARCL2B (MIM 612940) and GO as well as ARCL3B
(Guernsey et al. 2009; Yildirim et al. 2011; Dimopoulou
et al. 2013; Scherrer et al. 2013).
Variable features of ARCL3 resulting from ALDH18A1
mutations include microcephaly and cataracts. Micro-
cephaly has been reported in 7/10 cases, a similar propor-
tion to that seen in patients with PYCR1 mutations. In
contrast, bilateral cataracts have been seen in 6/10 cases
and so appear more frequent than in patients with PYCR1
mutations, only ~10% of whom are affected (Zampatti
et al. 2012; Dimopoulou et al. 2013). Microcephaly and
cataracts in particular, and also symptoms of develop-
mental delay, hypotonia with ascending spastic paraplegia
and contractures, and hypogenesis of the corpus callosum
represent an overlap in phenotype between ARCL3A and
Warburg Micro syndrome (WARBM, MIM 600118,
614225, 614222)(Handley et al. 2013)(see Table 1). In this
study, we show that the overlapping features of ARCL3A
and WARBM also extend to the cellular level, with fibro-
blasts derived from an ARCL3A patient displaying a lipid
droplet (LD) phenotype very similar to that recently
reported in WARBM (Liegel et al. 2013).
The patients in this study are the only two boys born
to healthy nonrelated Lebanese parents. Patient 1 was first
seen when he was 18 months old. At birth, his weight
was 2700 g, and his length 48.5 cm. According to the
parents, he was quiet, hypotonic, had few episodes of
constipation that required glycerin suppositories, and
redundant skin that disappeared around the age of 1 year.
At 7 months, he was diagnosed to have bilateral cataracts
that were removed surgically. Upon examination, his
weight was 8.1 kg (3rd percentile), height 77.5 cm (5th
percentile), and head circumference 42.3 cm (<3rd per-
centile). He had a small and receding forehead, a flat
occiput, deeply set eyes, cupped, simple, large ears, a
hooked nose with a prominent columella, short philtrum,
long, thin fingers with some ulnar deviation. External
genitalia showed bilateral ascended testes. Neurological
examination revealed a hypotonic boy, unable to support
himself in sitting, decreased muscle bulk, and increased
deep tendon reflexes. Ophthalmological examination
revealed the presence of a bilateral aphakia. Abdominal
ultrasonography and echocardiography did not show any
abnormalities. A brain MRI was performed and revealed
thinning of the corpus callosum with enlargement of the
subarachnoid space anteriorly within the hemispheric fis-
sure, lateral and 3rd ventricles were prominent in size
without evidence for hydrocephaly, cerebellar hypoplasia,
mildly delayed myelination, a mega cisterna magna, small
optic chiasm, and abnormal lenses within the globes.
Auditory evoked potential was normal. A total body x-ray
revealed a short left first metacarpal, and a bilateral coxa
valga. Upon several examinations, the clinical course was
unremarkable except that he had severe developmental
delay. At the last follow-up, he was 11 years old. He
could not sit unaided and was speechless. Head circum-
ference was 43 cm, height 104 cm, and weight 12 kg (all
values largely below the third percentile). In addition, to
the known features, he had deep set eyes, prominent








Postnatal growth retardation + + +
Postnatal microcephaly ++ ++ ++
Cognitive impairment ++ + ++
Hypotonia ++ ++ ++
Athetoid movements + + +
Contractures + + +
Neuropathy +  +
Corpus callosum dysgenesis +/ +/ ++
Cataracts + +/ ++
Microphthalmia   +
Microcornea   +
Hypogonadism +/  +
Cutis laxa + ++ 
‘++’ indicates a prominent manifestation of the syndrome whereas ‘+’ indicates a commonly encountered trait and ‘’ a rarely encountered trait.
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cheeks, hypoplastic alae nasi, very thin skin with visible
fine vessels, and multiple joint contractures.
Patient 2 was first evaluated by us at the age of 1 year. At
birth, his weight was 2600 g, and his length 49 cm. His
clinical course was identical to that of his affected brother
except that he did not have cataracts, and had a normal
skin appearance at birth. At examination, he was 5 years
and 9 months. His weight was 11 kg, height 92.5 cm, and
head circumference 39.7 cm (<3rd percentile). Physical
examination showed the same dysmorphic features present
in his brother with the addition of camptodactyly to the left
fingers. Abdominal ultrasonography did not show any
abnormalities. Metabolic screening was carried out for both
patients and no anomalies found. Serum and urine amino
acids, urine organic acids, very long chain fatty acid
(VLCFA), phytanic acid, electrolytes, aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT), creatine
kinase (CK), carnitine, acylcarnitine, acylglycine and tests
for congenital disorders of glycosylation were all normal.
In order to identify the genetic basis for the disease,
whole-exome sequencing was carried out using DNA
from patient 1. A total of 51,366 exonic variants were
identified and previously reported variants were filtered
according to functional effect and frequency data from
the Exome variant server and 1000 genomes project (see
Data S1). Synonymous variants and variants with a fre-
quency >0.002 in the general population were excluded
from analysis. Among the remaining 441 rare variants, we
identified two novel missense mutations in ALDH18A1,
c.2246G>A, p.Arg749Gln and c.2294G>A, p.Arg765Gln.
These mutations were confirmed by Sanger sequencing
and were present in both affected siblings. The
c.2246G>A, p.Arg749Gln mutation was transmitted by the
father and the c.2294G>A, p.Arg765Gln mutation by the
mother (Fig. 1A). Neither mutation was identified in
>400 control chromosomes. Because of the clinical over-
lap between ARCL3A and WARBM, we carried out
screening for ALDH18A1 mutations in an additional 51
families with a WARBM phenotype but in whom there
were no identified mutations in the known disease genes,
RAB3GAP1, RAB3GAP2, RAB18, or TBC1D20. This
cohort is detailed in Handley et al. (2013). No further
likely pathogenic mutations were identified and the cod-
ing variants c.896C>T, p.Thr299Ile (rs2275272), and
c.1115C>A, p.Ser372Tyr (rs3765571), were seen at a fre-
quency consistent with that in the general population
(10/50 and 3/50 respectively).
Both of the identified ALDH18A1 mutations are in the
last coding exon of the gene and affect a highly conserved
C-terminal domain of the encoded protein in which path-
ogenic mutations have been described previously (Bicknell
et al. 2008; Zampatti et al. 2012) (see Fig. 1B). Further-
more, software tools including Mutation Taster and Poly-
Phen-2 indicated that they were likely to be damaging.
Therefore, in order to determine the consequence of the
mutations on mRNA and protein expression, we carried
out qPCR and Western blot analysis on fibroblasts derived
from one of the patients and two control individuals. We
found that levels of ALDH18A1 mRNA were comparable
between patient and control lines (Fig. 1C); but that levels
of ALDH18A1 protein were clearly reduced in the patient
cells (Fig. 1D). Reduced ALDH18A1/PYCR1 protein
expression has previously been reported in ARCL3
(Baumgartner et al. 2000; Martinelli et al. 2012). There-
fore, taken together, these data indicate that the identified
ALDH18A1 mutations are pathogenic and that one or
both of them has an effect on protein stability.
The mechanism for ARCL3A disease pathogenesis is
not yet clear. Initial reports showed that a c.251G>A
mutation leading to a p.Arg84Gln substitution in the con-
served c-glutamyl kinase domain of ALDH18A1 are asso-
ciated with impaired enzymatic activity, and reduced
ornithine, citrulline, arginine, and proline and paradoxical
hyperammonemia in patients (Baumgartner et al. 2000,
2005). Furthermore, similar findings have been made in a
patient carrying a heterozygous de novo c.277G>A muta-
tion leading to a p.Gly93Arg substitution (Martinelli et al.
2012). However, these metabolic features have not been
observed in patients carrying other mutations (Bicknell
et al. 2008; Skidmore et al. 2011; Zampatti et al. 2012).
In vitro analysis of patient fibroblasts carrying a
c.2350C>T, p.His784Tyr mutation in a domain of the
protein thought to be involved in oligomerization, for
example, show normal proline synthesis (Bicknell et al.
2008). These data suggest that nonsynonymous mutations
or splicing mutations may differentially affect protein
expression or function while at the same time contribut-
ing to an otherwise broadly similar disease phenotype.
Both ALDH18A1 and PYCR1 are mitochondrial
proteins, and mutations in PYCR1 have been linked to
mitochondrial dysfunction and increased susceptibility to
oxidative stress (Reversade et al. 2009). However, corre-
sponding experiments on cells deficient in ALDH18A1
have not identified a similar cellular phenotype (Martinel-
li et al. 2012). Accordingly, labeling of ALDH18A1
(p.Arg749Gln/Arg765Gln) fibroblasts with the mitochon-
drial marker Mitotracker red CMXRos (Life technologies,
Paisley, UK) and an antibody to the mitochondrial pro-
tein COXIV (New England Biolabs, Hitchin, UK) did not
identify any gross morphological abnormalities or defects
in the filamentous mitochondrial network as compared to
controls (Fig. S1A). Furthermore, there was no differential
effect of H2O2-induced oxidative stress on these cells (Fig.
S1B). We extended our investigation to include other
intracellular compartments, but identified no alterations
in endoplasmic reticulum (ER) labeled with an antibody
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against protein disulfide isomerise (PDI), cis-Golgi labeled
with an antibody against GM130, trans-Golgi labeled with
an antibody against golgin-97 or endosomes labeled with
an antibody against EEA1 (Fig. S2).
In a recent study, WARBM has been linked to a cellu-
lar deficit in LD formation. Not only in human fibro-
blasts deficient in RAB3GAP1, RAB18, or TBC1D20, but
also in mouse embryonic fibroblasts (mEFs) deficient in
Tbc1d20, there is a significant increase in LD size when
cells are treated with oleate for 18 or 24 h to induce LD
formation (Liegel et al. 2013). We hypothesized that the
similarities in the clinical presentation of WARBM and
ARCL3A might be reflected at the cellular level and so
characterized LD formation in the ALDH18A1
(p.Arg749Gln/Arg765Gln) cells. As shown in Figure 2A
and B, we loaded cells with 400 lmol/L oleate complexed
Figure 1. Novel compound heterozygous mutations in ALDH18A1 cause ARCL3A. (A) Two affected children from a Lebanese family carry both a
paternally inherited c.2246G>A, and a maternally inherited c.2294G>A mutation in ALDH18A1. Patient (upper) and reference (lower)
electropherograms show these sequence changes, which lead to nonsynonymous p.Arg749Gln and p.Arg765Gln mutations in the encoded
ALDH18A1 protein. Mutations were confirmed by direct sequencing. Nucleotide numbering reflects cDNA numbering with +1 corresponding to
the A of the ATG translation initiation codon in the reference sequence NM_002860.3. Peptide residue numbering reflects protein primary
structure with p.Met1 corresponding to the first methionine in the reference sequence NP_002851.2. (B) Multiple sequence alignment of
ALDH18A1 ortholouges from various species shows that Arg749 and Arg765 are located in a highly conserved C-terminal domain of the protein
close to the site of other residues reported as mutated in ARCL3A, Ser742 (Zampatti et al. 2012), and His784 (Bicknell et al. 2008). The
alignment was generated using ClustalW software (Thompson et al. 1994). (C) Quantitative RT-PCR shows that expression of the ALDH18A1
transcript is similar in control and patient-derived fibroblasts. Data shown are derived from analysis of 6 cDNAs per genotype, each analysed in
triplicate. Primers were designed using the Universal ProbeLibrary Assay Design Center (Roche, Welwyn Garden City, UK) and are listed in
supplemental methods (Table S1). Error bars represent SEM. (D) Western blotting shows that levels of ALDH18A1 protein are reduced in patient-
derived fibroblasts. Blotting for COXIV serves as a control. Each lane on the blots shown corresponds to an individual lysate sample, and each blot
is representative of at least two independent experiments.
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to BSA in full media for 6, 18, and 24 h and then fixed
the cells and stained them with the neutral lipid stain
BODIPY. Confocal microscopy with subsequent analysis
using the thresholding and ‘analyse particles’ tools on
imageJ showed that LDs are enlarged in ALDH18A1
(p.Arg749Gln/Arg765Gln) cells as compared to two con-
trol fibroblast cell lines following both 18 and 24 h oleate
treatment (Fig. 2B). The uptake of lipid by individual
cells is highly variable. We therefore carried out addi-
tional experiments in which cells were again loaded with
oleate but this time labeled with the vital LD stain BO-
DIPY 558/568 C12 (Life Technologies) (Wang et al.
2010). Lipid uptake of individual cells was then quantified
by FACS analysis and confirmed that this is increased in
ALDH18A1(p.Arg749Gln/Arg765Gln) cells (Fig. 2C).
Because the observed LD phenotype strongly resembled
that of the WARBM cell lines, we carried out Western
blotting for the WARBM gene products RAB3GAP1,
RAB3GAP2, RAB18, and TBC1D20. However, there was
no change in the levels of these proteins in ALDH18A1
(p.Arg749Gln/Arg765Gln) cells as compared to the con-
trol lines. These data suggest that the LD phenotype in
the ALDH18A1(p.Arg749Gln/Arg765Gln) cells is the
result of a deficiency in a parallel pathway leading to
aberrant LD formation rather than in a pathway that
overlaps that involving the WARBM proteins at a
molecular level.
Together, the above data identify two novel patho-
genic mutations in ALDH18A1 as causative in ARCL3A
and aberrant LD formation as a cellular phenotype asso-
ciated with this disease. The mechanism by which mito-
chondrial ALDH18A1 dysfunction affects LDs is unclear,
though a working hypothesis is that the metabolic defi-
ciency resulting from ALDH18A1-loss might disrupt cel-
lular homeostasis. This might result in changes in LDs
as there are many ways in which LDs and mitochondria
are linked functionally. For example, LDs store cellular
cholesterol esters and triglycerides whereas the initiation
of steroid synthesis from cholesterol and fatty acid
oxidation following lipolysis occurs in mitochondria
(Walther and Farese 2012). It is also unclear, as yet,
whether ARCL3A pathology is directly linked to LD
dysfunction or whether both are linked to an underlying
deficit. However, it is intriguing that LD dysfunction
appears to be a cellular correlate for the similar pheno-
types associated with multiple inherited diseases. LD
defects have not only been found associated with WAR-
BM, but also in several other similar syndromes. For
example, mutations in SPG20/Spartin (MIM 607111) are
associated with Troyer syndrome, a complex form of
hereditary spastic paraplegia (MIM 275900) characterized
by short stature and cognitive deficits in addition to
progressive ascending spasticity. SPG20 has been found
Figure 2. A lipid droplet (LD) phenotype in ALDH18A1-mutant
fibroblasts. (A) Treatment of ALDH18A1(p.Arg749Gln/Arg765Gln)
fibroblasts for 24 h with 400 lmol/L oleate and subsequent staining
of LDs with BODIPY493/503 (green) revealed a greater size of LDs
when compared to controls. DNA was stained with DAPI (blue).
Scale bars = 10 lm. (B) Quantification of LD size in ALDH18A1
(p.Arg749Gln/Arg765Gln) fibroblasts and two control fibroblasts lines
following 6 h 18 h and 24 h treatment with 400 lmol/L oleate.
Data shown are derived from five frames/condition using the
‘analyse particles’ tool on imageJ and are representative of three
independent experiments. (C) Quantification of lipid uptake by
FACS. Control and ALDH18A1(p.Arg749Gln/Arg765Gln) fibroblasts
were treated for 18 h with 400 lmol/L oleate labeled with BODIPY
558/568 C12 and the fluorescence intensity of individual cells
measured by FACS. Data shown correspond to average fluorescence
from >3 replicate samples/genotype and are representative of at
least two independent experiments. (D) Western blotting shows that
levels of RAB3GAP2, RAB3GAP1, TBC1D20, and RAB18 proteins are
unchanged in patient-derived fibroblasts as compared to controls.
Blotting for b-tubulin serves as a control. Each lane on the blots
shown corresponds to an individual lysate sample, and each blot is
representative of at least two independent experiments. Error bars
represent SEM.
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to associate with both LDs and mitochondria, and
SPG20 deficiency has been linked to LD enlargement
and accumulation (Lu et al. 2006; Eastman et al. 2009).
Future work should seek to establish the extent to which
this phenotype is indicative of a common pathology. In
particular, it would be interesting to determine whether
the LD dysregulation is a feature of ARCL3A resulting
from other mutations in ALDH18A1, or indeed, ARCL
resulting from mutations in other genes.
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